Can-Fite BioPharma Ltd. (CANF.TA)

ILA 1.6

(6.67%)

Total Debt Summary of Can-Fite BioPharma Ltd.

  • Can-Fite BioPharma Ltd.'s latest annual total debt in 2023 was 40 Thousand USD , down -35.48% from previous year.
  • Can-Fite BioPharma Ltd.'s latest quarterly total debt in 2023 FY was 40 Thousand USD , down -35.48% from previous quarter.
  • Can-Fite BioPharma Ltd. reported annual total debt of 62 Thousand USD in 2022, down -50.0% from previous year.
  • Can-Fite BioPharma Ltd. reported annual total debt of 124 Thousand USD in 2021, up 85.07% from previous year.
  • Can-Fite BioPharma Ltd. reported quarterly total debt of 40 Thousand USD for 2023 FY, down -35.48% from previous quarter.
  • Can-Fite BioPharma Ltd. reported quarterly total debt of 66 Thousand USD for 2023 Q2, up 37.5% from previous quarter.

Annual Total Debt Chart of Can-Fite BioPharma Ltd. (2023 - 2011)

Historical Annual Total Debt of Can-Fite BioPharma Ltd. (2023 - 2011)

Year Total Debt Total Debt Growth
2023 40 Thousand USD -35.48%
2022 62 Thousand USD -50.0%
2021 124 Thousand USD 85.07%
2020 67 Thousand USD -10.67%
2019 75 Thousand USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%

Peer Total Debt Comparison of Can-Fite BioPharma Ltd.

Name Total Debt Total Debt Difference
Matricelf Ltd 1.24 Million ILA 96.779%